Lpl Financial LLC Vertex Pharmaceuticals Inc Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

A detailed history of Lpl Financial LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Lpl Financial LLC holds 189,713 shares of VRTX stock, worth $77.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
189,713
Previous 209,839 9.59%
Holding current value
$77.4 Million
Previous $98.4 Million 10.29%
% of portfolio
0.04%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$460.0 - $505.78 $9.26 Million - $10.2 Million
-20,126 Reduced 9.59%
189,713 $88.2 Million
Q2 2024

Aug 07, 2024
BUY
$392.81 - $485.53 $10.4 Million - $12.9 Million
26,468 Added 14.43%
209,839 $98.4 Million
Q1 2024

May 10, 2024
BUY
$407.69 - $446.08 $8.05 Million - $8.8 Million
19,735 Added 12.06%
183,371 $76.7 Million
Q4 2023

Feb 14, 2024
SELL
$343.0 - $410.68 $3.46 Million - $4.15 Million
-10,101 Reduced 5.81%
163,636 $66.6 Million
Q3 2023

Nov 13, 2023
BUY
$338.18 - $362.46 $577,949 - $619,444
1,709 Added 0.99%
173,737 $60.4 Million
Q2 2023

Jul 31, 2023
BUY
$314.42 - $351.91 $1.42 Million - $1.59 Million
4,528 Added 2.7%
172,028 $60.5 Million
Q1 2023

May 10, 2023
BUY
$283.23 - $323.1 $612,060 - $698,219
2,161 Added 1.31%
167,500 $52.8 Million
Q4 2022

Feb 07, 2023
BUY
$285.76 - $321.48 $9.22 Million - $10.4 Million
32,264 Added 24.24%
165,339 $47.7 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $750,568 - $837,457
-2,741 Reduced 2.02%
133,075 $38.5 Million
Q2 2022

Aug 12, 2022
SELL
$234.96 - $292.55 $161,652 - $201,274
-688 Reduced 0.5%
135,816 $38.3 Million
Q1 2022

May 16, 2022
BUY
$221.42 - $260.97 $3.54 Million - $4.18 Million
16,002 Added 13.28%
136,504 $35.6 Million
Q4 2021

Feb 14, 2022
BUY
$177.01 - $223.45 $1.4 Million - $1.77 Million
7,919 Added 7.03%
120,502 $26.5 Million
Q3 2021

Nov 15, 2021
BUY
$181.39 - $202.99 $7.09 Million - $7.93 Million
39,081 Added 53.17%
112,583 $20.4 Million
Q2 2021

Aug 13, 2021
BUY
$187.49 - $221.1 $1.89 Million - $2.23 Million
10,071 Added 15.88%
73,502 $14.8 Million
Q1 2021

May 14, 2021
BUY
$207.02 - $241.31 $4.29 Million - $5 Million
20,735 Added 48.56%
63,431 $13.6 Million
Q4 2020

Feb 12, 2021
SELL
$207.01 - $276.09 $459,355 - $612,643
-2,219 Reduced 4.94%
42,696 $10.1 Million
Q3 2020

Nov 09, 2020
BUY
$255.65 - $303.1 $210,399 - $249,451
823 Added 1.87%
44,915 $12.2 Million
Q2 2020

Aug 13, 2020
BUY
$225.48 - $295.8 $871,254 - $1.14 Million
3,864 Added 9.61%
44,092 $12.8 Million
Q1 2020

May 14, 2020
BUY
$199.77 - $247.81 $567,147 - $703,532
2,839 Added 7.59%
40,228 $9.57 Million
Q4 2019

Feb 14, 2020
BUY
$166.71 - $223.91 $178,046 - $239,135
1,068 Added 2.94%
37,389 $8.19 Million
Q3 2019

Nov 13, 2019
SELL
$166.23 - $187.09 $657,107 - $739,566
-3,953 Reduced 9.82%
36,321 $6.15 Million
Q2 2019

Aug 09, 2019
SELL
$164.61 - $190.37 $462,554 - $534,939
-2,810 Reduced 6.52%
40,274 $7.39 Million
Q1 2019

May 08, 2019
SELL
$163.73 - $194.7 $65,000 - $77,295
-397 Reduced 0.91%
43,084 $7.93 Million
Q4 2018

Feb 07, 2019
SELL
$151.91 - $192.21 $116,211 - $147,040
-765 Reduced 1.73%
43,481 $7.21 Million
Q3 2018

Nov 14, 2018
BUY
$167.73 - $192.74 $524,323 - $602,505
3,126 Added 7.6%
44,246 $8.53 Million
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $297,268 - $346,718
2,040 Added 5.22%
41,120 $6.99 Million
Q1 2018

May 15, 2018
SELL
$151.6 - $177.13 $598,213 - $698,954
-3,946 Reduced 9.17%
39,080 $6.37 Million
Q4 2017

Feb 14, 2018
BUY
$137.28 - $155.55 $808,167 - $915,722
5,887 Added 15.85%
43,026 $6.45 Million
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $3.47 Million - $3.8 Million
23,396 Added 170.24%
37,139 $5.65 Million
Q2 2017

Aug 14, 2017
BUY
N/A
13,743
13,743 $1.77 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email